Salt Lake City, United States
Leash Bio, founded in 2021 and headquartered in the United States, is poised to revolutionize the intersection of Biotechnology and Pharmaceutical industries. With its slogan, "Unleashing machine learning to solve medicinal chemistry," the company aims to overcome a significant hurdle in the field: the absence of high-quality, well-structured experimental datasets necessary for machine learning breakthroughs.
By leveraging automated in-house protein production and DNA-encoded chemical libraries, Leash Bio is developing comprehensive datasets of physical measurements across numerous targets and compounds. Their approach is expected to facilitate the creation of generalizable ML models capable of innovating novel medicines and proteins.
The company recently secured a $9.30M seed investment on 01 April 2024, supported by renowned investors like Mitsui Global Investment, Metaplanet Holdings, MFV Partners, Top Harvest Capital, Chris Gibson, Blake Borgeson, and SpringTide. This injection of capital underscores investor confidence in their pioneering approach.
